Reductive Activation of Mitomycin C by NADH:Cytochrome b5 Reductase

Cancer Research

Volumn 53, Issue 20, 1993, Pages 4907-4912

  Hodnick, William F ^a   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B5 REDUCTASE; DICOUMAROL; MITOMYCIN C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AEROBIC METABOLISM; ALKYLATION; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELL HYPOXIA; DRUG ACTIVATION; ENZYME ACTIVITY; HEMOLYTIC UREMIC SYNDROME; MOUSE; NONHUMAN; OXIDATIVE STRESS; PH; PRIORITY JOURNAL; RABBIT;

AEROBIOSIS; ALKYLATION; ANIMAL; BIOTRANSFORMATION; CELL HYPOXIA; CELL LINE; CYTOCHROME REDUCTASES; ERYTHROCYTES; KINETICS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MITOMYCIN; NAD; NADP; OXIDATION-REDUCTION; RABBITS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0027429970     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Pan, S., Andrews, P. A., Glover, C. J., and Bachur, N. R., Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem., 259: 959-966, 1984.
2. Pritsos, C. A. and Sartorelli, A. C., Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res., 46: 3528-3532, 1986.
3. Gustafson, D. L., and Pritsos, C. A. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst., 84: 1180-1185, 1992.
4. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C., Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44: 5638-5643, 1984.
5. Siegal, D., Gibson, N. W., Preusch, P. C., and Ross, D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50: 7483-7489, 1990.
6. Teicher, B. A., Lazo, J. S., and Sartorelli, A. C., Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res., 41: 73-81, 1981.
7. Kennedy, K. A., Rockwell, S. and Sartorelli, A. C., Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res., 40: 2356-2360, 1980.
8. Reed, D. J., Regulation of reductive processes by glutathione. Biochem. Pharmacol., 35: 7-13, 1986.
9. Kimpel, D. L., and Sagone, A. L., Effects of mitomycin C on metabolism in a rat liver preparation. Biochem. Pharmacol., 33: 3479-3484, 1984.
10. Fisher, J. and Olsen, R. Mechanistic aspects of mitomycin C activation by flavopro-tein transhydrogenases. Dev. Biochem., 21: 240-243, 1982.
11. Kennedy, K. A., McGurl, J. D., Leondaridis, L. and Alabaster, O. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Res., 45: 3541-3547, 1985.
12. Keyes, S. R., Rockwell, S. and Sartorelli, A. C., Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Cancer Res., 49: 3310-3313, 1989.
13. Rockwell, S. In vivo-in vitro tumor systems: new models for studying the response of tumors in therapy. Lab. Anim. Sci., 27: 831-851, 1977.
14. Rockwell, S., Kallman, R. F., and Fajardo, L. F., Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst., 49: 735-749, 1972.
15. Wheeler, G. P., Bowdon, B. J., Gremsley, J. A., and Lloyd, H. H., Interrelationships of some chemical, physiochemical, and biological activities of several l-(2-haloethyl)-1-nitrosoureas. Cancer Res., 34: 194-200, 1974.
16. 5 reductase of rabbit erythrocytes. J. Biochem. (Tokyo), 91: 1467-1477, 1982.
17. Aust, S. D., Morehouse, L. E., and Thomas, C. E., Role of metals in oxygen radical reactions. J. Free Radicals Biol. Med., 1: 3-25, 1985.
18. Scopes, R. K., Protein Purification: Principles and Practice, p. 16. New York: Springer-Verlag, 1982.
19. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
20. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Proven-zano, M. D., Fujimato, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C., Measurement of protein using bicinchoninic acid. Anal. Biochem., 150: 76-85, 1985.
21. Ernster, L. DT-Diaphorase. Methods Enzymol., 10: 309-317, 1967.
22. Slater, E. C., Uncouplers and inhibitors of oxidative phosphorylation. In: R.M. Hochster and J.H. Quastel (eds.), Metabolic Inhibitors, Vol. II, pp. 503-516. New York: Academic Press, 1963.
23. Sartorelli, A. C., Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res., 48: 775-778, 1988.
24. Kennedy, K. A., Teicher, B. A., Rockwell, S. and Sartorelli, A. C., Chemotherapeutic approaches to cell populations of tumors. In: A. C., Sartorelli, J. S., Lazo, and J.R. Bertino (eds.), Molecular Actions and Targets for Cancer Chemotherapeutic Agents, pp. 85-101. New York: Academic Press, 1981.
25. Lin, A. J., Cosby, L. A., and Sartorelli, A. C., Potential bioreductive alkylating agents. In: A. C. Sartorelli (ed.), Cancer Chemotherapy, pp. 71-86. Washington, DC: American Chemical Society, 1976.
26. Powis, G. Metabolism and reactions of quinoid anticancer agents. Pharmacol. & Ther., 35: 57-162, 1987.
27. Keyes, S. R., Heimbrook, D. C., Fracasso, P. M., Rockwell, S., Sligar, S. G., and Sartorelli, A. C., Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C. Adv. Enzyme Regul., 23: 291-307, 1985.
28. Schwartz, H. S., Pharmacology of mitomycin C. III. In vitro metabolism by rat liver. J. Pharmacol. Exp. Then, 136: 250-258, 1962.
29. Kennedy, K. A., Mimnaugh, E. G., Trash, M. A., and Sinha, B. K., Effects of glutathione and ethylxanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumor nuclei. Cancer Res., 45: 4071-4076, 1985.
30. Kennedy, K. A., Sligar, S. G., Polomski, L. and Sartorelli, A. C., Metabolic activation of mitomycin C by liver microsomes and nuclei. Biochem. Pharmacol., 31: 2011-2016, 1982.
31. Iyanagi, T. and Yamazaki, I. One-electron-transfer reactions in biochemical systems. III. One-electron reduction of quinones by microsomal flavin enzymes. Biochim. Biophys. Acta, 172: 370-381, 1969.
32. Powis, G. and Appel, P. L., Relationship of the single-electron reduction potential of quinones to their reduction by flavoproteins. Biochem. Pharmacol., 29: 2567-2572, 1980.
33. Powis, G., Svingen, B. A., and Appel, P. Quinone-stimulated superoxide formation by subcellular fractions, isolated hepatocytes, and other cells. Mol. Pharmacol., 20: 387-394, 1981.
34. 5 reductase. Proc. Natl. Acad. Sci. USA, 84: 3609-3613, 1987.
35. Williams, C. H., Jr. Flavin-containing dehydrogenases. In: P.D. Boyer (ed.), The Enzymes, Ed. 3, Vol. XIII, pp. 89-173. New York: Academic Press, 1976.
36. Lown, J. W., Begleiter, A., Johnson, D. and Morgan, A. R., Studies related to antitumor antibiotics. Part V. Reactions of mitomycin C with DNA examined by ethidium fluorescence assay. Can. J. Biochem., 54: 110-119, 1976.
37. Tomasz, M. and Lipman, R. Alkylation reactions of mitomycin C at acid pH.J. Am. Chem. Soc., 101: 6063-6067, 1979.
38. Begleiter, A., Robotham, E., Lacey, G. and Leith, M. K., Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett., 45: 173-176, 1989.
39. Gustafson, D. L., and Pritsos, C. A. Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol. Cancer Res., 52: 6936-6939, 1992.
40. Keyes, S. R., Loomis, R., DiGiovanna, M. P., Pritsos, C. A., Rockwell, S. and Sartorelli, A. C., Cytotoxicity and DNA cross-links produced by mitomycin analogs in aerobic and hypoxic EMT6 cells. Cancer Commun., 3: 351-356, 1991.
41. Mahler, H. R., Raw, I., Molinari, R. and do Amaral, D. F., Studies of electron transport enzymes. II. Isolation and some properties of a cytochrome-specific reduced diphos-phopyridine nucleotide dehydrogenase from pig liver. J. Biol. Chem., 233: 230-239, 1958.
42. Marshall, R. S., and Rauth, A. M., Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant. Cancer Res., 46: 2709-2713, 1986.
43. Hatherill, J. R., Till, G. O., and Ward, P. A., Mechanisms of oxidant-induced changes in erythrocytes. Agents Actions, 32: 351-358, 1991.
44. Caprari, P., Bozzi, A., Ferroni, L., Giuliani, A. Furciniti La Chiusa, B., Strom, R. and Salvati, A. M., Membrane alterations in G6PD- and PK-deficient erythrocytes exposed to oxidizing agents. Biochem. Med. Metab. Biol., 45: 16-27, 1991.
45. Verweij, J. van der Burg, M.E.L. and Pinedo, H. M., Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary, and cardiac side effects of the drag. Radiother. Oncol., 8: 33-41, 1987.